Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

67%

2 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 4
1(50.0%)
Phase 3
1(50.0%)
2Total
Phase 4(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT00227344Phase 4Terminated

CACAF2 Study: Catheter Ablation for Cure of Atrial Fibrillation

Role: lead

NCT00137540Phase 3Completed

FLAT Study: First Line Ablation Therapy for Treatment of Paroxysmal Atrial Fibrillation (RAAFT)

Role: lead

NCT00812916Completed

European Carto® XP REgistry for Validating Specialized CFAE SOftware

Role: lead

All 3 trials loaded